First-line serplulimab for advanced squamous non-small cell lung cancer: A multicenter, single-arm, real-world ASTRUM 004R study

被引：0
|
作者：
Shen, B. [1 ,2 ,3 ]
Yu, Z. [4 ]
Ding, H. [5 ]
Wang, H. [6 ]
Li, J. [7 ]
Xu, X. [8 ]
Tian, G. [9 ]
Han, G. [10 ]
Yin, L. [11 ]
Ji, Y. [12 ]
Zhou, Z. [13 ]
Zhou, L. [14 ]
Zhang, X. [15 ]
Sun, C. [16 ]
Ding, N. [17 ]
机构：
[1] Nanjing Med Univ, Jiangsu Canc Hosp, Med Oncol Dept, Nanjing, Peoples R China
[2] Nanjing Med Univ, Jiangsu Inst Canc Res, Nanjing, Peoples R China
[3] Nanjing Med Univ, Canc Hosp, Nanjing, Peoples R China
[4] Cent S Univ, Xiangya Hosp, Changsha 410008, Hunan, Peoples R China
[5] First Peoples Hosp Zhenjiang, Dept Respirat, Zhenjiang, Peoples R China
[6] Chinese Peoples Liberat Army Gen Hosp, Med Ctr 1, Dept Oncol, Beijing, Peoples R China
[7] Wuhu Second Peoples Hosp, Dept Resp Med, Wuhu, Peoples R China
[8] Linyi Peoples Hosp, Dept Resp Med, Linyi, Peoples R China
[9] Jining Med Coll, Affiliated Hosp, Dept Resp Med, Jining, Peoples R China
[10] Taizhou Peoples Hosp, Dept Med Oncol, Taizhou, Peoples R China
[11] Dalian Med Univ, Affiliated Hosp 1, Dept Med Oncol, Dalian, Peoples R China
[12] Anyang Canc Hosp, Dept Internal Med, Anyang, South Korea
[13] First Peoples Hosp Yancheng, Dept Respirat, Yancheng, Peoples R China
[14] Nanjing Med Univ, Jiangsu Prov Hosp, Affiliated Hosp 1, Dept Resp Med, Nanjing, Peoples R China
[15] Qingdao Cent Hosp, Dept Stereotact Radiotherapy, Qingdao 266000, Peoples R China
[16] Yangzhou Univ, Canc Inst, Northern Jiangsu Peoples Hosp, Coll Med, Yangzhou 255000, Jiangsu, Peoples R China
[17] Wuxi Huishan Dist Peoples Hosp, Oncol Dept, Wuxi, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.10.715
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
682P
引用
收藏
页码：S1660 / S1660
页数：1
相关论文
共 50 条
  • [21] First-line Afatinib for Non-Small Cell Lung Cancer in Real World Practice
    Kim, Y.
    Sun, J.
    Park, K.
    Park, S. E.
    Lee, S.
    Ahn, M.
    Ahn, J. S.
    Lim, S. W.
    Lee, H.
    Cho, J. H.
    Kim, H. K.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2209 - S2209
  • [22] A Better Real World Practice for Pemetrexed in First-Line Treatment of Advanced Mon-Squamous Non-Small Cell Lung Cancer
    Zhang, Y.
    Yan, B.
    Yang, H.
    Yang, N.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S627 - S627
  • [23] A real-world cohort study of first-line afatinib in patients with EGFR-mutant advanced non-small cell lung cancer in Vietnam
    Cam Phuong Pham
    Thi Thai Hoa Nguyen
    Anh Tu Do
    Tuan Khoi Nguyen
    Thi Anh Thu Hoang
    Tuan Anh Le
    Dinh Thy Hao Vuong
    Dac Nhan Tam Nguyen
    Van Khiem Dang
    Thi Oanh Nguyen
    Van Luan Pham
    Minh Hai Nguyen
    Thi Huyen Trang Vo
    Hung Kien Do
    Ha Thanh Vu
    Thi Thuy Hang Nguyen
    Van Thai Pham
    Le Huy Trinh
    Khac Dung Nguyen
    Hoang Gia Nguyen
    Cong Minh Truong
    Tran Minh Chau Pham
    Thi Bich Phuong Nguyen
    BMC Cancer, 24
  • [24] A real-world cohort study of first-line afatinib in patients with EGFR-mutant advanced non-small cell lung cancer in Vietnam
    Pham, Cam Phuong
    Nguyen, Thi Thai Hoa
    Do, Anh Tu
    Nguyen, Tuan Khoi
    Hoang, Thi Anh Thu
    Le, Tuan Anh
    Vuong, Dinh Thy Hao
    Nguyen, Dac Nhan Tam
    Dang, Van Khiem
    Nguyen, Thi Oanh
    Pham, Van Luan
    Nguyen, Minh Hai
    Vo, Thi Huyen Trang
    Do, Hung Kien
    Vu, Ha Thanh
    Nguyen, Thi Thuy Hang
    Pham, Van Thai
    Trinh, Le Huy
    Nguyen, Khac Dung
    Nguyen, Hoang Gia
    Truong, Cong Minh
    Pham, Tran Minh Chau
    Nguyen, Thi Bich Phuong
    BMC CANCER, 2024, 24 (01)
  • [25] Real-World Study of Patients With EGFR Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer Treated With First-Line Osimertinib
    Nieva, J.
    Taylor, A.
    Servidio, L.
    Sun, P.
    Okhuoya, P.
    Horvat, P.
    Tolani, E.
    Magee, K.
    Mathur, R.
    Balakrishna, S.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1113 - S1113
  • [26] Sintilimab with chemotherapy as first-line treatment for locally advanced or metastatic squamous non-small-cell lung cancer: a real-world data study
    Lin, Xinqing
    Deng, Haiyi
    Li, Suyang
    Xie, Xiaohong
    Chen, Chao
    Cai, Longqiu
    Yang, Yilin
    Qiu, Guihuan
    Xie, Zhanhong
    Qin, Yinyin
    Liu, Ming
    Zhou, Chengzhi
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (02) : 757 - 764
  • [27] Sintilimab with chemotherapy as first-line treatment for locally advanced or metastatic squamous non-small-cell lung cancer: a real-world data study
    Xinqing Lin
    Haiyi Deng
    Suyang Li
    Xiaohong Xie
    Chao Chen
    Longqiu Cai
    Yilin Yang
    Guihuan Qiu
    Zhanhong Xie
    Yinyin Qin
    Ming Liu
    Chengzhi Zhou
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 757 - 764
  • [28] Real-World Costs of Adverse Events in First-Line Treatment of Metastatic Non-Small Cell Lung Cancer
    Engel-Nitz, Nicole M.
    Johnson, Michael P.
    Bunner, Scott H.
    Ryan, Kellie J.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2020, 26 (06): : 729 - 740
  • [29] Fruquintinib with gefitinib as first-line therapy in patients carrying EGFR mutations with advanced non-small cell lung cancer: a single-arm, phase II study
    Lu, Shun
    Zhou, Jian-Ying
    Niu, Xiao-Min
    Zhou, Jian-Ya
    Jian, Hong
    Yin, Hong-Yan
    Guan, Sha
    Wang, Lin-Fang
    Li, Ke
    He, James
    Su, Wei-Guo
    TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (02) : 839 - +
  • [30] Real-world clinical outcomes among patients with advanced non-small cell lung cancer who initiated first-line regimens
    Nadler, Eric
    Arondekar, Bhakti
    Aguilar, Kathleen
    Zhou, Jie
    Chang, Jane
    Zhang, Xinke
    Pawar, Vivek
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
12345